Answers are grounded in this paper and cite their sources.
Meta-analysis evaluates RAVER1 phosphorylation in human cells, suggesting implications for therapeutic strategies.
RAVER1 is a conserved PTBP1-associated regulator of alternative splicing with emerging roles in cytoskeletal organisation and proliferative signaling. Despite the central role of phosphorylation in intracellular signaling, phospho-dependent regulation of RAVER1 remains poorly defined. To address this gap, we performed a comprehensive meta-analysis of global human cellular phosphoproteome datasets to characterise RAVER1 phosphorylation and its associated signaling networks. Class I phosphosites were systematically compiled, and phosphosite-centric analyses were conducted to evaluate site predominance, co-occurrence patterns, phosphoproteome-wide co-regulation, and predicted upstream kinase associations. Thirteen Class I phosphosites were identified, of which S14, S17, and T463 emerged as predominant based on consistent detection across profiling and differential datasets. Significant phosphosite co-occurrence among S6, T8, and S14 within the N-terminal region suggests coordinated, context-dependent regulation and functional association of these sites. Phosphoproteome-wide co-regulation analysis linked RAVER1 phosphorylation states to proteins involved in RNA processing, cell-cycle regulation, and DNA repair. Kinase-oriented analyses identified CDK family members (CDK9, CDK12, and CDK13) as high-confidence predicted upstream kinases for RAVER1 S14. Notably, phosphosites in several epithelial–mesenchymal transition (EMT)-associated regulators, including KDM1A, VIM, and PTK2, showed positive co-regulation with RAVER1 phosphosites, consistent with multi-omics perturbation datasets reporting EMT-associated changes upon RAVER1 depletion. To our knowledge, this study provides the first phospho-signaling map of RAVER1 and establishes a phosphosite-centric analytical framework for functional investigation of RAVER1 phosphorylation, with potential implications for targeted therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Sanjeev et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: